Kidney Transplant Therapeutics – Applying New Evidence to Improve Long-term Graft Survival

ACKNOWLEDGEMENT

This activity is supported by an independent educational grant from Sanofi US.

TUITION

Complimentary

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

LIVE ACTIVITY DATE OF RELEASE

Tuesday, August 23, 2022 from 1:00pm – 2:00pm ET

LIVE CREDIT DESIGNATION STATEMENT

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ENDURING MATERIAL DATE OF RELEASE/EXPIRATION

The enduring material will be available from August 23, 2022 to August 23, 2023.

ENDURING CREDIT DESIGNATION STATEMENT

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

• Describe the role of the immune response to kidney allograft with a focus on how it impacts the efficacy of immunosuppression and the critical importance of adherence to immunosuppressive regimens
• Summarize current clinical evidence for the efficacy of immunosuppressive regimens to prevent acute and long-term graft rejection
• Apply the KDIGO 2020 guideline for Evaluation and Management of Candidates for Kidney Transplantation, with a focus on patients with a history of cardiovascular disease and non-adherence

TARGET AUDIENCE

The primary target audience includes transplant surgeons, nephrologists, and nephrology nurses.

ESTIMATED TIME TO COMPLETE

1 hour

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.ClinicalSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Name of Faculty or Presenter	Reported Financial Relationship
Yolanda Becker, MD, FACS, FAST (Ret) Professor of Surgery University of Chicago Medicine Director, Career Development TCU School of Medicine	Nothing to disclose
John J. Friedewald, MD, FASN Professor of Medicine and Surgery Division of Nephrology and the Comprehensive Transplant Center Northwestern University	Grant/Research Support: CSL Behring, Eurofins Viracor, Hansa, NIH, Regeneron, Veloxis Consultant/Advisory Board: eGenesis, Sanofi, Transplant Genomics, Veloxis
Michelle A. Josephson, MD Medical Director, Kidney and Pancreas Transplantation Professor of Medicine and Surgery University of Chicago	Grant/Research Support: Bucksbaum Institute, Gift of Hope, NIH Consultant/Advisory Board: Exosome, Immucor, Otsuka, UBC Pharmaceutical Support, Vera Therapeutics Non-Mutual funds/Stock Ownership/Stock Options: Seagen

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner	Reported Financial Relationship
Carole Drexel Medical Director PlatformQ Health Education, LLC	Nothing to disclose
Colleen Heffner Medical Director PlatformQ Health Education, LLC	Nothing to disclose

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Jaimee Harris-Gold, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact ClinicalSeriesLive.com at 877-394-1306 or at Support@ClinicalSeriesLive.com.